- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in closed-loop insulin delivery
Authors
Keywords
Type 1 diabetes, Closed loop insulin delivery, Artificial pancreas, Diabetes technology
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 127, Issue -, Pages 154953
Publisher
Elsevier BV
Online
2021-12-08
DOI
10.1016/j.metabol.2021.154953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up
- (2021) Coralie Amadou et al. DIABETES CARE
- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- Fully Automated Artificial Pancreas for Adults with Type 1 Diabetes using Multiple Hormones: Exploratory Experiments
- (2021) Dorsa Majdpour et al. Canadian Journal of Diabetes
- Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study
- (2021) Charlotte K. Boughton et al. DIABETES OBESITY & METABOLISM
- Impact of hybrid closed loop therapy on hypoglycemia awareness in individuals with type 1 diabetes and impaired hypoglycemia awareness
- (2021) Marie-Anne Burckhardt et al. Diabetes Technology & Therapeutics
- New closed-loop insulin systems
- (2021) Charlotte K. Boughton et al. DIABETOLOGIA
- Transforming type 1 diabetes: the next wave of innovation
- (2021) Daniel J. Drucker DIABETOLOGIA
- Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
- (2021) Luz E. Castellanos et al. DIABETES CARE
- One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
- (2021) Marc D. Breton et al. Diabetes Technology & Therapeutics
- Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes
- (2021) Julia Fuchs et al. Frontiers in Pediatrics
- 98-LB: Diabeloop DBL4K Hybrid Closed-Loop System Improves Time-in-Range without Increasing Time-in-Hypoglycemia in Children Aged 6–12 Years
- (2021) DULANJALEE KARIYAWASAM et al. DIABETES
- 212-OR: Closed-Loop Increases Time-in-Range in Older Adults with Type 1 Diabetes Compared with Sensor-Augmented Pump Therapy: A Randomized Crossover Trial
- (2021) SYBIL A. MCAULEY et al. DIABETES
- 70-OR: Evaluation of the Omnipod 5 Automated Insulin Delivery System in Very Young Children with Type 1 Diabetes (T1D)
- (2021) JENNIFER SHERR et al. DIABETES
- 214-OR: Cambridge Hybrid Closed-Loop in Children and Adolescents with T1D: A Multicentre Six-Month Randomised Trial
- (2021) JULIA FUCHS et al. DIABETES
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users
- (2021) Julien Da Silva et al. Diabetes Technology & Therapeutics
- Adjunctive Therapies to Optimize Closed-loop Glucose Control
- (2021) Shylaja Srinivasan et al. Journal of diabetes science and technology
- Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes
- (2021) Mary B. Abraham et al. JAMA Pediatrics
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial
- (2020) Ahmad Haidar et al. DIABETES CARE
- Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry
- (2020) Martin Tauschmann et al. DIABETES CARE
- What training, support and resourcing do health professionals need to support people using a closed-loop system? A qualitative interview study with health professionals involved in the Closed Loop from Onset in type 1 Diabetes (CLOuD) trial
- (2020) Barbara Kimbell et al. Diabetes Technology & Therapeutics
- Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
- (2020) Nicklas J Johansen et al. Lancet Diabetes & Endocrinology
- Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIAL Study
- (2020) Hood Thabit et al. DIABETES CARE
- Effect of Afrezza on Glucose Dynamics During HCL Treatment
- (2020) Alfonso Galderisi et al. DIABETES CARE
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes
- (2020) Richard E. Pratley et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
- (2020) Sybil A. McAuley et al. DIABETES CARE
- Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial
- (2020) Leah M. Wilson et al. DIABETES CARE
- A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
- (2020) Marc D. Breton et al. NEW ENGLAND JOURNAL OF MEDICINE
- ADO09 , a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G , lowers postprandial blood glucose versus insulin lispro in type 1 diabetes
- (2020) Grit Andersen et al. DIABETES OBESITY & METABOLISM
- A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System
- (2020) John Lum et al. Diabetes Technology & Therapeutics
- Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers
- (2020) Laya Ekhlaspour et al. Diabetes Technology & Therapeutics
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes
- (2019) Sémah Tagougui et al. Frontiers in Endocrinology
- Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial
- (2019) Ulrike Schierloh et al. PLoS One
- Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
- (2019) Julia Lawton et al. Diabetes Technology & Therapeutics
- Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial
- (2019) Martin Tauschmann et al. DIABETES CARE
- A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm
- (2019) Laurel H. Messer et al. Diabetes Technology & Therapeutics
- Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
- (2019) Klemen Dovc et al. DIABETES CARE
- Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
- (2019) Rayhan A Lal et al. ENDOCRINE REVIEWS
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop
- (2019) Rayhan A. Lal et al. DIABETES CARE
- Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial
- (2019) Klemen Dovc et al. DIABETES CARE
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
- (2019) Melissa H. Lee et al. DIABETES CARE
- Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system
- (2019) Cari Berget et al. PEDIATRIC DIABETES
- Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults
- (2018) Jennifer L. Sherr DIABETES CARE
- Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial
- (2018) Zoe A. Stewart et al. DIABETES CARE
- Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
- (2018) T. M. Peters et al. DIABETIC MEDICINE
- Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
- (2018) Gregory P. Forlenza et al. DIABETES CARE
- Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
- (2018) C. K. Boughton et al. DIABETIC MEDICINE
- Is insulin pump therapy effective in Type 1 diabetes?
- (2018) J. C. Pickup DIABETIC MEDICINE
- First Look at Control-IQ: A New-Generation Automated Insulin Delivery System
- (2018) Sue Brown et al. DIABETES CARE
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
- (2018) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
- (2017) Firas H El-Khatib et al. LANCET
- Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
- (2017) Lia Bally et al. Lancet Diabetes & Endocrinology
- Multinational Home Use of Closed-Loop Control Is Safe and Effective
- (2016) Stacey M. Anderson et al. DIABETES CARE
- Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial
- (2016) Martin Tauschmann et al. DIABETES CARE
- Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
- (2014) Yue Ruan et al. DIABETOLOGIA
- Intensive insulin therapy for critically ill subjects based on direct data-driven model predictive control
- (2014) Youqing Wang et al. JOURNAL OF PROCESS CONTROL
- Use of a “Fuzzy Logic” Controller in a Closed-Loop Artificial Pancreas
- (2013) Richard Mauseth et al. Diabetes Technology & Therapeutics
- Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
- (2013) Richard M. Bergenstal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas
- (2008) S. A. Weinzimer et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More